The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Trastuzumab Monoclonal Antibody Market Research Report 2024

Global Trastuzumab Monoclonal Antibody Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1739071

No of Pages : 86

Ask Your Query

Synopsis
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.

Global Trastuzumab Monoclonal Antibody market is projected to reach US$ 6303.7 million in 2029, increasing from US$ 4512 million in 2022, with the CAGR of 4.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Trastuzumab Monoclonal Antibody market research.

Key manufacturers engaged in the Trastuzumab Monoclonal Antibody industry include Roche, Amgen, Pfizer, Organon, Teva and Viatris, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Trastuzumab Monoclonal Antibody were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Trastuzumab Monoclonal Antibody market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Trastuzumab Monoclonal Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Roche
  • Amgen
  • Pfizer
  • Organon
  • Teva
  • Viatris

Segment by Type

  • Brand
  • Biosimilar

Segment by Application

  • Breast Cancer
  • Stomach Cancer

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Trastuzumab Monoclonal Antibody report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Trastuzumab Monoclonal Antibody Market Overview
1.1 Product Overview and Scope of Trastuzumab Monoclonal Antibody
1.2 Trastuzumab Monoclonal Antibody Segment by Type
1.2.1 Global Trastuzumab Monoclonal Antibody Market Value Comparison by Type (2023-2029)
1.2.2 Brand
1.2.3 Biosimilar
1.3 Trastuzumab Monoclonal Antibody Segment by Application
1.3.1 Global Trastuzumab Monoclonal Antibody Market Value by Application: (2023-2029)
1.3.2 Breast Cancer
1.3.3 Stomach Cancer
1.4 Global Trastuzumab Monoclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global Trastuzumab Monoclonal Antibody Revenue 2018-2029
1.4.2 Global Trastuzumab Monoclonal Antibody Sales 2018-2029
1.4.3 Global Trastuzumab Monoclonal Antibody Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Trastuzumab Monoclonal Antibody Market Competition by Manufacturers
2.1 Global Trastuzumab Monoclonal Antibody Sales Market Share by Manufacturers (2018-2023)
2.2 Global Trastuzumab Monoclonal Antibody Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Trastuzumab Monoclonal Antibody Average Price by Manufacturers (2018-2023)
2.4 Global Trastuzumab Monoclonal Antibody Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Trastuzumab Monoclonal Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Trastuzumab Monoclonal Antibody, Product Type & Application
2.7 Trastuzumab Monoclonal Antibody Market Competitive Situation and Trends
2.7.1 Trastuzumab Monoclonal Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Trastuzumab Monoclonal Antibody Players Market Share by Revenue
2.7.3 Global Trastuzumab Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Trastuzumab Monoclonal Antibody Retrospective Market Scenario by Region
3.1 Global Trastuzumab Monoclonal Antibody Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Trastuzumab Monoclonal Antibody Global Trastuzumab Monoclonal Antibody Sales by Region: 2018-2029
3.2.1 Global Trastuzumab Monoclonal Antibody Sales by Region: 2018-2023
3.2.2 Global Trastuzumab Monoclonal Antibody Sales by Region: 2024-2029
3.3 Global Trastuzumab Monoclonal Antibody Global Trastuzumab Monoclonal Antibody Revenue by Region: 2018-2029
3.3.1 Global Trastuzumab Monoclonal Antibody Revenue by Region: 2018-2023
3.3.2 Global Trastuzumab Monoclonal Antibody Revenue by Region: 2024-2029
3.4 North America Trastuzumab Monoclonal Antibody Market Facts & Figures by Country
3.4.1 North America Trastuzumab Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Trastuzumab Monoclonal Antibody Sales by Country (2018-2029)
3.4.3 North America Trastuzumab Monoclonal Antibody Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Trastuzumab Monoclonal Antibody Market Facts & Figures by Country
3.5.1 Europe Trastuzumab Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Trastuzumab Monoclonal Antibody Sales by Country (2018-2029)
3.5.3 Europe Trastuzumab Monoclonal Antibody Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Trastuzumab Monoclonal Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Trastuzumab Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Trastuzumab Monoclonal Antibody Sales by Country (2018-2029)
3.6.3 Asia Pacific Trastuzumab Monoclonal Antibody Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Trastuzumab Monoclonal Antibody Market Facts & Figures by Country
3.7.1 Latin America Trastuzumab Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Trastuzumab Monoclonal Antibody Sales by Country (2018-2029)
3.7.3 Latin America Trastuzumab Monoclonal Antibody Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Trastuzumab Monoclonal Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Trastuzumab Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Trastuzumab Monoclonal Antibody Sales by Country (2018-2029)
3.8.3 Middle East and Africa Trastuzumab Monoclonal Antibody Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Trastuzumab Monoclonal Antibody Sales by Type (2018-2029)
4.1.1 Global Trastuzumab Monoclonal Antibody Sales by Type (2018-2023)
4.1.2 Global Trastuzumab Monoclonal Antibody Sales by Type (2024-2029)
4.1.3 Global Trastuzumab Monoclonal Antibody Sales Market Share by Type (2018-2029)
4.2 Global Trastuzumab Monoclonal Antibody Revenue by Type (2018-2029)
4.2.1 Global Trastuzumab Monoclonal Antibody Revenue by Type (2018-2023)
4.2.2 Global Trastuzumab Monoclonal Antibody Revenue by Type (2024-2029)
4.2.3 Global Trastuzumab Monoclonal Antibody Revenue Market Share by Type (2018-2029)
4.3 Global Trastuzumab Monoclonal Antibody Price by Type (2018-2029)
5 Segment by Application
5.1 Global Trastuzumab Monoclonal Antibody Sales by Application (2018-2029)
5.1.1 Global Trastuzumab Monoclonal Antibody Sales by Application (2018-2023)
5.1.2 Global Trastuzumab Monoclonal Antibody Sales by Application (2024-2029)
5.1.3 Global Trastuzumab Monoclonal Antibody Sales Market Share by Application (2018-2029)
5.2 Global Trastuzumab Monoclonal Antibody Revenue by Application (2018-2029)
5.2.1 Global Trastuzumab Monoclonal Antibody Revenue by Application (2018-2023)
5.2.2 Global Trastuzumab Monoclonal Antibody Revenue by Application (2024-2029)
5.2.3 Global Trastuzumab Monoclonal Antibody Revenue Market Share by Application (2018-2029)
5.3 Global Trastuzumab Monoclonal Antibody Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Trastuzumab Monoclonal Antibody Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amgen Trastuzumab Monoclonal Antibody Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Trastuzumab Monoclonal Antibody Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Organon
6.4.1 Organon Corporation Information
6.4.2 Organon Description and Business Overview
6.4.3 Organon Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Organon Trastuzumab Monoclonal Antibody Product Portfolio
6.4.5 Organon Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Trastuzumab Monoclonal Antibody Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Viatris
6.6.1 Viatris Corporation Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Viatris Trastuzumab Monoclonal Antibody Product Portfolio
6.6.5 Viatris Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Trastuzumab Monoclonal Antibody Industry Chain Analysis
7.2 Trastuzumab Monoclonal Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Trastuzumab Monoclonal Antibody Production Mode & Process
7.4 Trastuzumab Monoclonal Antibody Sales and Marketing
7.4.1 Trastuzumab Monoclonal Antibody Sales Channels
7.4.2 Trastuzumab Monoclonal Antibody Distributors
7.5 Trastuzumab Monoclonal Antibody Customers
8 Trastuzumab Monoclonal Antibody Market Dynamics
8.1 Trastuzumab Monoclonal Antibody Industry Trends
8.2 Trastuzumab Monoclonal Antibody Market Drivers
8.3 Trastuzumab Monoclonal Antibody Market Challenges
8.4 Trastuzumab Monoclonal Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock